International Flavors & Fragrances Inc. (IFF)
NYSE: IFF · Real-Time Price · USD
77.48
-0.99 (-1.26%)
May 13, 2026, 4:00 PM EDT - Market closed
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 2.51B | 2.48B | 2.43B | | | | | |
| 1.17% | 2.18% | - | | | | | |
| 3.32B | 3.28B | 3.37B | | | | | |
Food Ingredients Revenue Growth | 1.31% | -2.58% | - | | | | | |
Health & Biosciences Revenue | 2.34B | 2.28B | 2.20B | | | | | |
Health & Biosciences Revenue Growth | 2.41% | 3.63% | 5.86% | | | | | |
| 2.52B | 2.48B | 2.44B | | | | | |
| 1.49% | 1.64% | 1.92% | | | | | |
| - | 369.00M | 1.05B | | | | | |
Pharma Solutions Revenue Growth | - | -64.82% | 11.00% | | | | | |
| 103.00M | - | - | | | | | |
| 10.79B | 10.89B | 11.48B | | | | | |
| -0.94% | -5.17% | 0.04% | | | | | |
Adjusted EBITDA
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Taste Adjusted Operating EBITDA | 500.00M | 478.00M | 460.00M | | | | | |
Taste Adjusted Operating EBITDA Growth | 4.60% | 3.91% | - | | | | | |
Food Ingredients Adjusted Operating EBITDA | 426.00M | 423.00M | 408.00M | | | | | |
Food Ingredients Adjusted Operating EBITDA Growth | 0.71% | 3.68% | - | | | | | |
Health & Biosciences Adjusted Operating EBITDA | 609.00M | 594.00M | 577.00M | | | | | |
Health & Biosciences Adjusted Operating EBITDA Growth | 2.53% | 2.95% | -1.87% | | | | | |
Scent Adjusted Operating EBITDA | 519.00M | 515.00M | 545.00M | | | | | |
Scent Adjusted Operating EBITDA Growth | 0.78% | -5.50% | 18.22% | | | | | |
Pharma Solutions Adjusted Operating EBITDA | - | 76.00M | 215.00M | | | | | |
Pharma Solutions Adjusted Operating EBITDA Growth | - | -64.65% | 8.04% | | | | | |
| 794.00M | -382.00M | 766.00M | | | | | |
Capital Expenditures
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Nourish Capital Expenditures | 322.00M | 235.00M | | | | | |
Nourish Capital Expenditures Growth | 37.02% | -6.75% | | | | | |
Health & Biosciences Capital Expenditures | 145.00M | 73.00M | | | | | |
Health & Biosciences Capital Expenditures Growth | 98.63% | -14.12% | | | | | |
Scent Capital Expenditures | 89.00M | 70.00M | | | | | |
Scent Capital Expenditures Growth | 27.14% | 12.90% | | | | | |
Pharma Solutions Capital Expenditures | 38.00M | 85.00M | | | | | |
Pharma Solutions Capital Expenditures Growth | -55.29% | -18.27% | | | | | |
Updated May 5, 2026. Data Source:
Fiscal.ai.
